课题基金 / 基金详情

ABNORMAL PRESSURE NATRIURESIS IN HYPERTENSION

ABNORMAL PRESSURE NATRIURESIS IN HYPERTENSION
高血压患者压力异常尿钠
批准号:
2459901
负责人:
Jacqueline Novak
金额:
$2.86万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-08-01 至

项目摘要

项目成果

Jacqueline Novak的其他基金

相似基金

相关文献

中文摘要
翻译
有相当多的证据支持这种理论,即某种形式的
英文摘要
There is considerable evidence to support the theory that some form of renal dysfunction plays a role in the development and maintenance of hypertension. In several forms of genetic hypertension, a common defect has been identified in the pressure natriuresis relationship. The defect in hypertensive animals is partly due to an inability to transmit renal perfusion pressure into the renal interstitium. The goal of this proposal is to examine possible mechanism that mediate this intrarenal abnormality. In recent studies, endothelin (ET) and nitric oxide (NO) have been shown to have significant effects on renal excretory function and that synthesis of these factors may be altered in hypertension. The main objective of this proposal is to test the hypothesis that the inability to transmit the renal perfusion pressure into the renal interstitium is due to abnormalities in the renal autocoids such as NO and ET. A variety of techniques including microcirculatory, whole kidney, and whole animal will be used to examine the roles of ET and NO in contributing to the abnormal pressure natriuresis in different models of hypertension. The questions that will be addressed are: 1) Is the inability to transmit renal perfusion pressure into the renal interstitium in Dahl S rats due to a decrease in NO synthesis? 2) By what mechanism does L-arginine restore the normal pressure natriuresis relationship in Dahl S rats? Does L-arginine improve transmission of RPP into the renal interstitium by affecting medullary hemodynamics? 3) Does chronic renal interstitial infusion of a NO synthase inhibitor into Dahl R rats render them salt- sensitive? 4) What role does ET play in the abnormal pressure natriuresis in various forms of hypertension? Does infusion of an ET receptor antagonist improve the transmission of RPP into the renal interstitium? 5) What role does ET lay in the progression of hypertension: Does chronic infusion of an ET receptor antagonist lead to long-term reductions in arterial pressure in various forms of hypertension?
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Role of nitric oxide in modulating the long-term renal and hypertensive actions of norepinephrine.
一氧化氮在调节去甲肾上腺素的长期肾脏和高血压作用中的作用。
DOI: 10.1161/01.hyp.29.1.205
发表时间: 1997
期刊: Hypertension (Dallas, Tex. : 1979)
影响因子: --
作者: [Granger,J, Schnackenberg,C, Novak,J, Tucker,B, Miller,T, Morgan,S, Kassab,S]
通讯作者: Kassab,S
Reduced sensitivity of the renal circulation to angiotensin II in pregnant rats.
妊娠大鼠肾循环对血管紧张素 II 的敏感性降低。
DOI: 10.1161/01.hyp.30.3.580
发表时间: 1997
期刊: Hypertension (Dallas, Tex. : 1979)
影响因子: --
作者: [Novak,J, Reckelhoff,J, Bumgarner,L, Cockrell,K, Kassab,S, Granger,JP]
通讯作者: Granger,JP
Relaxin: A Novel HRT for Prevention of Cardiac Disease
  • 批准号:
    8180696
  • 项目类别:
  • 资助金额:
    $35.66万
  • 财政年份:
    2011
  • 负责人:
    Jacqueline Novak
  • 依托单位:
ABNORMAL PRESSURE NATRIURESIS IN HYPERTENSION
ABNORMAL PRESSURE NATRIURESIS IN HYPERTENSION
海外基金